A. Klimov

James A. Smagala, Erica D. Dawson, L. Gubareva, 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Receptor-binding properties of swine influenza viruses isolated and propagated in MDCK cells.

N. Bovin, A. Klimov, M. Matrosovich, 2005, Virus research.

Reply to Saito et al.

R. Garten, L. Gubareva, A. Klimov, 2008 .

Highly Pathogenic Avian Influenza A(H7N3) Virus in Poultry Workers, Mexico, 2012

C. Davis, N. Cox, S. Lindstrom, 2013, Emerging infectious diseases.

Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States

L. Gubareva, K. St. George, A. Klimov, 2011, Emerging infectious diseases.

Molecular Epidemiology of Influenza A(H1N1)pdm09 Viruses from Pakistan in 2009–2010

R. Garten, L. Gubareva, Xiyan Xu, 2012, PloS one.

Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season.

Michelle M. Packard, J. Guarner, S. Lindstrom, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses

L. Gubareva, Y. Shoji, A. Klimov, 2011, Human vaccines.

Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004

N. Cox, M. Shaw, T. Uyeki, 2009, Archives of Virology.

Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt.

L. Gubareva, A. Klimov, M. Saad, 2009, Journal of infection and public health.

Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996–2007

C. Macken, F. Hayden, M. Zambon, 2009, Antiviral therapy.

Antigenic and Genetic Diversity of Highly Pathogenic Avian Influenza A (H5N1) Viruses Isolated in Egypt

C. Davis, N. Cox, R. Donis, 2010, Avian diseases.

Pathogenicity of two Egyptian H5N1 highly pathogenic avian influenza viruses in domestic ducks

A. Selim, A. Arafa, M. Hassan, 2010, Archives of Virology.

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

N. Cox, A. Klimov, J. Katz, 2006, Vaccine.

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

N. Cox, A. Klimov, J. Katz, 2006, Vaccine.

Investigating a crow die-off in January–February 2011 during the introduction of a new clade of highly pathogenic avian influenza virus H5N1 into Bangladesh

Mustafizur Rahman, J. Teifke, S. Luby, 2014, Archives of Virology.

Detection and Characterization of Clade 7 High Pathogenicity Avian Influenza H5N1 Viruses in Chickens Seized at Ports of Entry and Live Poultry Markets in Vietnam

C. Davis, N. Cox, R. Donis, 2010, Avian diseases.

Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam.

C. Davis, N. Cox, S. Lindstrom, 2009, Virology.

Studies of a recombinant which inherited the haemagglutinin from the human influenza virus A/Hong Kong/1/68 (H3n2) and other genes from influenza virus A/duck/Ukraine/1/63 (H3N8).

A. Klimov, Y. Ghendon, V. Ginzburg, 1984, The Journal of general virology.

Emergence of multiple clade 2.3.2.1 influenza A (H5N1) virus subgroups in Vietnam and detection of novel reassortants.

C. Davis, S. Lindstrom, A. Creanga, 2013, Virology.

Development of a new candidate H5N1 avian influenza virus for pre‐pandemic vaccine production

Weizhong Yang, C. Davis, N. Cox, 2009, Influenza and other respiratory viruses.

Avian Influenza in Wild Birds, Central Coast of Peru

Bruno M. Ghersi, S. Lindstrom, D. Blazes, 2009, Emerging infectious diseases.

Assessment of development of resistance to antivirals in the ferret model of influenza virus infection.

A. Monto, A. Klimov, S. Ohmit, 2003, The Journal of infectious diseases.

Maternal influenza vaccination and effect on influenza virus infection in young infants.

K. O'Brien, T. Uyeki, A. Klimov, 2011, Archives of pediatrics & adolescent medicine.

Update: Influenza Activity — United States, September 30, 2012–February 9, 2013

L. Brammer, L. Finelli, N. Cox, 2013, MMWR. Morbidity and mortality weekly report.

Reassortment between avian apathogenic and human attenuated cold-adapted viruses as an approach for preparing influenza pandemic vaccines

N. Cox, A. Klimov, J. Katz, 2004 .

Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility in vitro

Ha T. Nguyen, M. Shaw, R. Garten, 2010, Antiviral therapy.

Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses

C. Macken, R. Webster, A. Monto, 2005, Antiviral therapy.

Comparative studies of A/Leningrad/134/57 wild-type and 47-times passaged cold-adapted mutant influenza viruses: oligonucleotide mapping and RNA-RNA hybridization studies.

N. Cox, A. Kendal, A. Klimov, 1985, The Journal of general virology.

Biochemical and serological studies of influenza B viruses: comparisons of historical and recent isolates.

J. Oxford, G. Schild, A. Klimov, 1984, Virus research.

No Evidence of Avian Influenza A H5N1 among Returning US Travelers

S. Lindstrom, T. Uyeki, M. Katz, 2007, Emerging infectious diseases.

Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus.

N. Cox, A. Kendal, A. Klimov, 1992, Virology.

Receptor Speciﬁcity of Inﬂuenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (cid:1)

N. Cox, R. Garten, Xiyan Xu, 2010 .

Influenza virus titration, antigenic characterization, and serological methods for antibody detection.

A. Klimov, J. Katz, Xiuhua Lu, 2012, Methods in molecular biology.

INFLUENZA SURVEILLANCE IN RUSSIA BASED ON EPIDEMIOLOGICAL AND LABORATORY DATA FOR THE PERIOD FROM 2005 TO 2012.

N. Cox, A. Klimov, V. Zarubaev, 2013, American journal of infectious diseases.

Influenza A and B Infection in Children in Urban Slum, Bangladesh

C. Bridges, R. Breiman, W. A. Brooks, 2007, Emerging infectious diseases.

Human Metapneumovirus Infection among Children, Bangladesh

C. Bridges, R. Breiman, W. A. Brooks, 2007, Emerging infectious diseases.

Low incidence of rimantadine resistance in field isolates of influenza A viruses.

N. Cox, A. Klimov, H. Regnery, 1999, The Journal of infectious diseases.

Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.

L. Gubareva, J. Bresee, A. Fiore, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.

Louis J. Cohen, R. Baldassano, A. Klimov, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Update: Influenza activity--United States, 2002-03 season.

L. Brammer, N. Cox, A. Klimov, 2003, MMWR. Morbidity and mortality weekly report.

Changes in the Receptor-Binding Properties of H3N2 Viruses during Long-Term Circulation in Humans

N. Bovin, A. Klimov, A. Gambaryan, 2019, Biochemistry (Moscow).

Clinical and virologic outcomes in patients with oseltamivir‐resistant seasonal influenza A (H1N1) infections: results from a clinical trial

L. Gubareva, E. Belongia, A. Klimov, 2011, Influenza and other respiratory viruses.

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective

James A. Smagala, L. Gubareva, A. Klimov, 2010, Viruses.

Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons.

Xiyan Xu, A. Klimov, B. Mungall, 2004, Virus research.

PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines.

N. Cox, A. Klimov, 1995, Journal of virological methods.

Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors

Xiyan Xu, E. Korchagina, A. Klimov, 2010, Glycoconjugate Journal.

Studies of fowl plague virus temperature-sensitive mutants with defects in transcription.

A. Hay, A. Klimov, Y. Ghendon, 1982, The Journal of general virology.

Analytical detection of influenza A(H3N2)v and other A variant viruses from the USA by rapid influenza diagnostic tests

R. Garten, J. Villanueva, A. Klimov, 2012, Influenza and other respiratory viruses.

Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses.

A. Klimov, J. Katz, L. Rudenko, 2006, Vaccine.

Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance

L. Gubareva, Xiyan Xu, G. Demmler-Harrison, 2010, Antimicrobial Agents and Chemotherapy.

Characterization of the epidemic influenza B viruses isolated during 2004-2005 season in Taiwan.

M. Shaw, A. Klimov, Jih-Hui Lin, 2007, Virus research.

Relation between drug resistance and antigenicity among norakin-resistant mutants of influenza A (fowl plague) virus

R. Webster, A. Klimov, H. Heider, 2005, Archives of Virology.

Detection of Molecular Markers of Antiviral Resistance in Inﬂuenza A (H5N1) Viruses Using a Pyrosequencing Method (cid:1)

S. Lindstrom, L. Gubareva, A. Klimov, 2009 .

Modified M2 proteins produce heterotypic immunity against influenza A virus.

A. Klimov, J. Katz, T. Rowe, 1999, Vaccine.

Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.

Ha T. Nguyen, Dayan Wang, L. Gubareva, 2013, Antiviral research.

Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing

C. Davis, Xiyan Xu, I. Barr, 2014, Vaccine.

Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).

T. Toner, A. Klimov, L. Rudenko, 2004, Virus research.

The development of vaccine viruses against pandemic A(H1N1) influenza.

C. Davis, N. Cox, Xiyan Xu, 2011, Vaccine.

Simultaneous Infection of Pigs and People with Triple‐Reassortant Swine Influenza Virus H1N1 at a U.S. County Fair

A. Vincent, S. Lindstrom, Xiyan Xu, 2013, Zoonoses and public health.

A severely immunocompromised child with uncomplicated oseltamivir‐resistant 2009 H1N1 pandemic influenza infection

E. Hyle, S. Lindstrom, M. Ferraro, 2012, Pediatric transplantation.

Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events.

N. Cox, S. Lindstrom, A. Klimov, 2004, Virology.

Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children.

W. C. Gamble, N. Cox, A. Klimov, 1995, The Journal of general virology.

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Ron A M Fouchier, Colin A Russell, Takato Odagiri, 2008, Vaccine.

Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. Commentary

C. Bridges, N. Cox, J. Nelson, 2006 .

Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants

A. Klimov, G. Alexandrova, F. Polezhaev, 1984, Infection and immunity.

Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons.

Yan Li, Xiyan Xu, N. Cox, 2002, Virology.

Molecular analysis of isolates from influenza B outbreaks in the U.S. and Nepal, 2005

M. Shaw, B. Arulanandam, R. Acharya, 2006, Archives of Virology.

Genetic and antigenic analysis of the neuraminidase of influenza B viruses: association of neuraminidase in global spread and recycling of influenza B/Victoria/2/87-like viruses

N. Cox, M. Shaw, S. Lindstrom, 2004 .

Multiple lineages co-circulation and genetic reassortment of the neuraminidase and hemagglutinin genes within influenza viruses of the same type/subtype

N. Cox, Xiyan Xu, A. Klimov, 2001 .

Transmission of influenza A viruses between pigs and people, Iowa, 2002–2004

C. Bridges, R. Garten, Xiyan Xu, 2010, Influenza and other respiratory viruses.

Absence of 2009 Pandemic H1N1 Influenza A Virus in Fresh Pork

A. Vincent, A. Klimov, A. Lorusso, 2009, PloS one.

Analysis of the genome of influenza A virus strains (H3N2) isolated during the epidemic season of 1982–1983

A. Klimov, Y. Ghendon, 2005, Archives of Virology.

Evolution of H5N1 Avian Influenza Viruses in Asia

Keiji Fukuda, David E. Swayne, Nguyen Tien Dung, 2005, Emerging infectious diseases.

Outbreak of Antiviral Drug–Resistant Influenza A in Long-Term Care Facility, Illinois, USA, 2008

L. Gubareva, J. Bresee, A. Klimov, 2009, Emerging infectious diseases.

Adamantane-Resistant Influenza Infection During the 2004–05 Season

Mahbubur Rahman, N. Cox, R. Greenlee, 2008, Emerging infectious diseases.

Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses

C. Macken, R. Webster, A. Monto, 2005, Antiviral Therapy.

Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.

N. Cox, H. Kantarjian, A. Klimov, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.

Alicia M. Fry, Michael W. Shaw, Larisa V. Gubareva, 2009, MMWR. Morbidity and mortality weekly report.

Transmission of Equine Influenza Virus to Dogs

Calvin M. Johnson, N. Cox, R. Donis, 2005, Science.

Isolation and Characterization of Avian Influenza Viruses, Including Highly Pathogenic H5N1, from Poultry in Live Bird Markets in Hanoi, Vietnam, in 2001

David E. Swayne, Amanda Balish, Timothy M. Uyeki, 2005, Journal of Virology.

Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza virus: detection of mutations in all genes of the A/Ann Arbor/6/60 (H2N2) mutant vaccine donor strain.

N. Cox, A. Kendal, A. Klimov, 1986, Microbial pathogenesis.

Microevolution of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Humans, Egypt, 2007–2011

S. Truelove, L. Gubareva, R. Donis, 2013, Emerging infectious diseases.

Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross‐reactivity with contemporary swine influenza virus antisera

A. Vincent, A. Klimov, K. Lager, 2010, Influenza and Other Respiratory Viruses.

Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.

C. Bridges, N. Cox, J. Nelson, 2006, The Journal of infectious diseases.

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.

R. Webby, Dayan Wang, N. Cox, 2012, Vaccine.

Comparative studies of H3N2 influenza virus strains isolated in May–June, 1982, and in the subsequent epidemic in February, 1983: Antigenic and genome analysis

A. M. Tikhonova, A. Klimov, M. Pereira, 2005, Archives of Virology.

Genome analysis of H1N1 influenza virus strains isolated in the U.S.S.R. during an epidemic in 1961–1962

A. Klimov, Y. Ghendon, 2005, Archives of Virology.

Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains.

A. Klimov, G. Alexandrova, F. Polezhaev, 1981, The Journal of general virology.

Investigation on the mechanisms of the failure of human influenza virus to replicate in chick embryo cell cultures.

A. Klimov, Y. Ghendon, S. Markushin, 1977, Acta virologica.

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

Larisa V. Gubareva, Xiyan Xu, R. Garten, 2008, Antimicrobial Agents and Chemotherapy.

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

N. Cox, M. Shaw, L. Gubareva, 2007, The Journal of infectious diseases.

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

Xiyan Xu, Xiaohong M Davis, N. Cox, 2005, The Lancet.

Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein

Fang Fang, Larisa V. Gubareva, R. Moss, 2009, PloS one.

Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir

F. Hayden, M. Zambon, M. Tashiro, 2003, Antimicrobial Agents and Chemotherapy.

Outbreak of Variant Influenza A(H3N2) Virus in the United States

L. Brammer, Karen K. Wong, M. Biggerstaff, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diagnosis of influenza from respiratory autopsy tissues: detection of virus by real-time reverse transcription-PCR in 222 cases.

S. Lindstrom, Xiyan Xu, R. Gao, 2011, The Journal of molecular diagnostics : JMD.

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.

W. Carr, N. Cox, K. Nichol, 2008, Archives of internal medicine.

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.

Amanda Balish, Xiyan Xu, Patricia Quinlisk, 2009, The New England journal of medicine.

Genomic Signature-Based Identification of Influenza A Viruses Using RT-PCR/Electro-Spray Ionization Mass Spectrometry (ESI-MS) Technology

R. Sampath, R. Garten, L. Gubareva, 2010, PloS one.

Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006–2008

M. Shaw, R. Garten, L. Gubareva, 2009, Influenza and other respiratory viruses.

Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.

Michael Shaw, Alicia M Fry, M. Shaw, 2012, Antiviral research.

Characteristics of Patients with Oseltamivir- Resistant

L. Gubareva, A. Klimov, C. Pan, 2011 .

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Lynnette Brammer, Alicia M Fry, L. Brammer, 2009, JAMA.

Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses

M. Eichelberger, D. Burke, Xiyan Xu, 2011, Proceedings of the National Academy of Sciences.

Global circulation patterns of seasonal influenza viruses vary with antigenic drift

Trevor Bedford, Colin A. Russell, Derek J. Smith, 2015, Nature.

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults.

Mark Wolff, W. Keitel, R. Belshe, 2002, Vaccine.

Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response.

L. Brammer, N. Cox, M. Shaw, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.

R. Garten, L. Gubareva, A. Klimov, 2010, Antiviral research.

Pathogenicity and Transmission in Pigs of the Novel A(H3N2)v Influenza Virus Isolated from Humans and Characterization of Swine H3N2 Viruses Isolated in 2010-2011

R. Webby, A. Vincent, P. Gauger, 2012, Journal of Virology.

Swine H3N2 Viruses Isolated in 2010-2011 from Humans and Characterization of Isolated the Novel A(H3N2)v Influenza Virus Pathogenicity and Transmission in Pigs of

R. Webby, A. Vincent, P. Gauger, 2012 .

Rapid Strategy for Screening by Pyrosequencing of Influenza Virus Reassortants - Candidates for Live Attenuated Vaccines

J. Villanueva, A. Klimov, M. Levine, 2014, PloS one.

Reassortment and evolution of current human influenza A and B viruses.

N. Cox, M. Shaw, S. Lindstrom, 2004, Virus research.

Genetic and Antigenic Analysis of the First A/New Caledonia/20/99-like H1N1 Influenza Isolates Reported in the Americas

K. Lohman, A. Klimov, L. Daum, 2002, Emerging infectious diseases.

Influenza: Propagation, Quantification, and Storage

A. Klimov, J. Katz, A. Balish, 2013, Current protocols in microbiology.

Influenza is a Major Contributor to Childhood Pneumonia in a Tropical Developing Country

Mustafizur Rahman, C. Bridges, Xiyan Xu, 2010, The Pediatric infectious disease journal.

Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011

Katrina Sleeman, Amanda Balish, Rebecca Garten, 2012, Emerging infectious diseases.

Comparative safety, immunogenicity, and efficacy of several anti‐H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine)

A. Klimov, A. Gambaryan, L. Rudenko, 2011, Influenza and other respiratory viruses.

Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use

Catherine Macken, Maria Zambon, Masato Tashiro, 2006, Antimicrobial Agents and Chemotherapy.

Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by Pyrosequencing

R. Garten, L. Gubareva, A. Klimov, 2009, Antimicrobial Agents and Chemotherapy.

Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010.

Amanda Balish, Xiyan Xu, Rebecca Garten, 2012, Virology.

Virology Journal BioMed Central

Nicolai V Bovin, N. Bovin, A. Klimov, 2008 .

Structural and Antigenic Variation among Diverse Clade 2 H5N1 Viruses

Samuel S. Shepard, C. Davis, Jessie C. Chang, 2013, PloS one.

Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs

James Paulson, Ruben O. Donis, Xiyan Xu, 2010, Journal of Virology.

Structural Stability of Influenza A(H1N1)pdm09 Virus Hemagglutinins

N. Cox, Jessie C. Chang, Hua Yang, 2014, Journal of Virology.

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11

Alicia M. Fry, Larisa V. Gubareva, Chao-Yang Pan, 2012, Emerging infectious diseases.

In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses

Vasiliy P. Mishin, Katrina Sleeman, Larisa V. Gubareva, 2010, Antimicrobial Agents and Chemotherapy.

Surveillance and impact of influenza in the United States.

L. Simonsen, N. Cox, K. Fukuda, 1999, Vaccine.

Update: influenza activity--United States, April-August 2009.

L. Brammer, A. Fowlkes, D. Swerdlow, 2009, MMWR. Morbidity and mortality weekly report.

Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009.

M. Shaw, Xiyan Xu, T. Uyeki, 2009, MMWR. Morbidity and mortality weekly report.

Swine Influenza Virus A (H3N2) Infection in Human, Kansas, USA, 2009

L. Finelli, S. Lindstrom, R. Garten, 2011, Emerging infectious diseases.

Outbreak of Influenza A (H3N2) Variant Virus Infection among Attendees of an Agricultural Fair, Pennsylvania, USA, 2011

L. Brammer, Karen K. Wong, M. Biggerstaff, 2012, Emerging infectious diseases.

Novel influenza A (H1N1) virus infections among health-care personnel - United States, April-May 2009.

Matthew E. Wise, David L. Swerdlow, Lyn Finelli, 2009, MMWR. Morbidity and mortality weekly report.

SARS Surveillance during Emergency Public Health Response, United States, March–July 2003

S. Schrag, C. Whitney, R. Khabbaz, 2004, Emerging infectious diseases.

A High Diversity of Eurasian Lineage Low Pathogenicity Avian Influenza A Viruses Circulate among Wild Birds Sampled in Egypt

C. Davis, R. Donis, A. Klimov, 2013, PloS one.

Evaluation of the Subtype Specificity of Monoclonal Antibodies Raised against H1 and H3 Subtypes of Human Influenza A Virus Hemagglutinins

N. Cox, A. Klimov, E. Varečková, 2002, Journal of Clinical Microbiology.

Update: influenza activity--United States, August 30, 2009-January 9, 2010.

L. Brammer, L. Finelli, N. Cox, 2010, MMWR. Morbidity and mortality weekly report.

Assaying Susceptibility of Avian and Other Influenza A Viruses to Zanamivir: Comparison of Fluorescent and Chemiluminescent Neuraminidase Assays

A. Klimov, X. Xu, B. Mungall, 2003, Avian diseases.

Evolution of the receptor binding phenotype of influenza A (H5) viruses.

A. Klimov, A. Gambaryan, A. Tuzikov, 2006, Virology.

Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.

Ha T. Nguyen, M. Shaw, R. Garten, 2010, Antiviral research.

Design and Performance of the CDC Real-Time Reverse Transcriptase PCR Swine Flu Panel for Detection of 2009 A (H1N1) Pandemic Influenza Virus

S. Lindstrom, J. Villanueva, A. Klimov, 2011, Journal of Clinical Microbiology.

Correlation of amino acid residues in the M1 and M2 proteins of influenza virus with high yielding properties.

A. Klimov, V. Ginzburg, N. G. Orlova, 1991, Virus research.

Inside Cover.fm

K. Lohman, A. Klimov, L. Daum, 2002 .

, Catherine Their Use Surveillance during the First 3 Years of Neuraminidase Inhibitors in Global Detection of Influenza Viruses Resistant to

C. Macken, R. Webster, A. Monto, 2006 .

Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model

N. Cox, Y. Matsuoka, R. Donis, 2014, Clinical and Vaccine Immunology.

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).

N. Cox, Y. Matsuoka, R. Donis, 2011, Virology.

[Growth characteristics of single gene mutants of A/Leningrad/134/57(H2N2) influenza virus and cold-adapted mutant A/Leningrad/134/17/57(H2N2)].

A. Klimov, L. Rudenko, I. Kiseleva, 2007, Voprosy virusologii.

Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y/I223R mutation from a child after prolonged treatment with oseltamivir.

Ha T. Nguyen, L. Gubareva, A. Klimov, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents.

R. Holman, N. Cox, N. Arden, 2000, Vaccine.

Nucleotide sequences of the neuraminidase genes of influenza A/Leningrad/134/57 (H2N2) virus and two of its live, attenuated, cold-adapted variants

N. Cox, A. Klimov, J. Romanova, 2005, Virus genes.

Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees

A. Klimov, G. Alexandrova, G. N. Budilovsky, 1984, Infection and immunity.

[Mutations in the genes coding for hemagglutinin and neuraminidase in cold-adapted variants of the influenza virus A/Leningrad/134/57 (H2N2)].

A. Klimov, T. Medvedeva, G. Aleksandrova, 1991, Voprosy virusologii.

Studies on a temperature-sensitive mutant of fowl plague virus having a mutation in gene 7 coding for the M protein.

A. Klimov, Y. Ghendon, S. Markushin, 1983, The Journal of general virology.

Multisite virological influenza surveillance in India: 2004–2008

Lalit Kant, Anand Krishnan, A. Krishnan, 2011, Influenza and other respiratory viruses.

Nucleotide sequence of RNA segment 7 and the predicted amino sequence of M1 and M2 proteins of FPV/Weybridge (H7N7) and WSN (H1N1) influenza viruses.

D. Nayak, A. Klimov, D. Nayak, 1988, Virus research.

Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.

A. Klimov, G. Alexandrova, T. Medvedeva, 1983, Acta virologica.

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season

Ha T. Nguyen, L. Gubareva, Xiyan Xu, 2013, Influenza and other respiratory viruses.

Surveillance of Influenza in Indonesia, 2003–2007

F. Mahoney, S. Lindstrom, T. Uyeki, 2012, Influenza and other respiratory viruses.

Investigating a crow die-off in January–February 2011 during the introduction of a new clade of highly pathogenic avian influenza virus H5N1 into Bangladesh

J. Teifke, S. Luby, R. Donis, 2014, Archives of Virology.

Shift Shown in Influenza A Adamantane Resistance—Reply

N. Cox, M. Shaw, D. Shay, 2006 .

Subtype H7 influenza viruses: comparative antigenic and molecular analysis of the HA-, M-, and NS-genes

A. Klimov, D. Bucher, S. Prösch, 2005, Archives of Virology.

Influenza A (H3N2) Outbreak, Nepal

Michael W. Shaw, James P. Chambers, Philip J. L. Gould, 2005, Emerging infectious diseases.

Influenza A ( H 3 N 2 ) Outbreak , Nepal

Philip J. L. Gould, M. Shaw, R. Acharya, 2019 .

Evolution of Highly Pathogenic H5N1 Avian Influenza Viruses in Vietnam between 2001 and 2007

Xiu-Feng Wan, Tung Nguyen, Amanda Balish, 2008, PloS one.

[Different receptor specificity of influence viruses from ducks and chickens and its reflection in the composition of sialosides on host cells and mucins].

N. Bovin, A. Klimov, M. Matrosovich, 2006, Voprosy virusologii.

Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010.

C. Davis, S. Lindstrom, R. Donis, 2012, Virology.

SURVEILLANCE FOR INFLUENZA - UNITED STATES, 1997–98, 1998–99, AND 1999–00 SEASONS

N. Cox, K. Fukuda, A. Klimov, 2002, Morbidity and mortality weekly report. Surveillance summaries.

Highly Pathogenic Avian Influenza A(H5N1) Viruses at the Animal–Human Interface in Vietnam, 2003–2010

C. Davis, L. Gubareva, James C. Kile, 2017, The Journal of infectious diseases.

Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production.

A. Klimov, William G. Davis, I. Kiseleva, 2013, Journal of virological methods.

[Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3].

A. Klimov, L. Rudenko, D. Swayne, 2009, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.

Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.

A. Klimov, L. Rudenko, A. Ramírez, 1996, Bulletin of the World Health Organization.

Role of individual genes of the A/Leningrad/134/17/57 (H2N2) cold-adapted donor strain in manifestation of the temperature-sensitive phenotype of reassortant influenza A viruses

T. Toner, A. Klimov, L. Rudenko, 2004 .

Multiple reassortment events among highly pathogenic avian influenza A(H5N1) viruses detected in Bangladesh.

C. Davis, S. Lindstrom, Mahmudur Rahman, 2014, Virology.

Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus

N. Cox, A. Klimov, I. Kiseleva, 2001 .

[Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].

A. Klimov, L. Rudenko, I. Kiseleva, 2005, Voprosy virusologii.

Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010.

R. Garten, L. Gubareva, A. Klimov, 2011, The Journal of infectious diseases.

Update: influenza activity - United States, September 28, 2008--January 31, 2009.

L. Brammer, C. Reed, L. Finelli, 2009, MMWR. Morbidity and mortality weekly report.

Update: influenza activity--United States, 2004-05 season.

L. Brammer, L. Rotz, N. Cox, 2005, MMWR. Morbidity and mortality weekly report.

[The NS gene--a possible determinant of apathogenicity of a cold-adapted donor of attenuation A /Leningrad/134/47/57 and its reassortants].

A. Klimov, A. I. Egorov, L. M. Garmashova, 1994, Voprosy virusologii.

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Henrik Nielsen, L. Mathiesen, C. Leen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genome analysis of influenza B virus strains isolated during epidemics in boarding schools

J. Oxford, A. Klimov, Y. Ghendon, 2005, Archives of Virology.

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

N. Cox, K. Fukuda, C. Bender, 1998, Science.

Early Detection of Pandemic (H1N1) 2009, Bangladesh

Mustafizur Rahman, J. Bresee, Mahmudur Rahman, 2012, Emerging infectious diseases.

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

K Cameron, Y. Guan, R. Webster, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.

K. Subbarao, A. Klimov, S. Hietala, 1999, The Journal of infectious diseases.

Cruise ships: high-risk passengers and the global spread of new influenza viruses.

M. Cetron, N. Cox, K. Fukuda, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans *

Y. Guan, R. Webster, N. Cox, 2002, Journal of medical virology.

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.

M. Meltzer, C. Bridges, N. Cox, 2000, JAMA.

Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs.

K Cameron, N. Cox, A. Hay, 2001, The Journal of general virology.

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.

N. Cox, C. Bender, K. Subbarao, 1999, Virology.

Selection of antigenically advanced variants of seasonal influenza viruses

D. Burke, Dayan Wang, N. Cox, 2016, Nature Microbiology.

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

L. Brammer, L. Gubareva, J. Bresee, 2009, JAMA.

Population-Based Surveillance for Zoonotic Influenza a Infections Among Agricultural Workers

A. Capuano, C. Lynch, G. Gray, 2006 .

Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010.

R. Garten, L. Gubareva, A. Klimov, 2011, The Journal of infectious diseases.

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

N. Cox, A. Klimov, L. Rudenko, 2006, Vaccine.

Pathogenicity and antigenicity of a new influenza a (H5N1) virus isolated from duck meat

N. Cox, A. Klimov, J. Katz, 2003, Journal of medical virology.

Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.

N. Cox, K. Fukuda, A. Klimov, 2002, Morbidity and mortality weekly report. Surveillance summaries.

Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.

R. Garten, L. Gubareva, A. Klimov, 2010, Antiviral research.

Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by Pyrosequencing

R. Garten, L. Gubareva, A. Klimov, 2009, Antimicrobial Agents and Chemotherapy.

Update: influenza activity - United States, August 30-October 31, 2009.

L. Brammer, L. Finelli, C. Bridges, 2009, MMWR. Morbidity and mortality weekly report.

6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry

N. Bovin, A. Klimov, M. Matrosovich, 2008, Virology Journal.